Jefferies Lifts Healthineers Target to 55 Euros as Bernstein Steps Back on Valuation
Published on 11/14/2026 at 15:12 | Editorial boerse-global.de
Jefferies raised its price target on Siemens Healthineers to 55 euros from 50 euros on November 8, keeping its rating at "Buy." The move puts the brokerage at the top of a cluster of bullish revisions: two other research houses lifted their targets on November 6 and 8 without touching their ratings, landing between 49 and 51 euros. The shares gained 1.1% on Friday.
Not everyone is leaning in. Bernstein Research downgraded the stock to "Market-Perform" from "Outperform," with analyst Susannah Ludwig trimming her target to 44 euros from 44.50 euros. Her reasoning: the improved valuation and the prospect of another year of only limited earnings per share growth leave little room for a further re-rating.
A €300 Million Breakup Bill
The split in analyst opinion lands against a busy stretch of corporate news. On November 5, Siemens Healthineers announced a savings program aimed at capping roughly 300 million euros in additional costs tied to its restructuring. The same day, the company kicked off the carve-out of its in-vitro diagnostics unit, which is to be established as a standalone business under the name Olyrian Diagnostics, with the transition slated for completion by mid-2028. According to Reuters, the group flagged China as a drag on diagnostics. Jobs will be affected by the restructuring program, the company said.
Should investors sell immediately? Or is it worth buying Siemens Healthineers?
Alongside the spinoff, Healthineers reported comparable revenue growth of 4.0% for fiscal 2026, with fourth-quarter comparable revenue up 5.9%.
A New Name and a Continuing Buyback
Subject to shareholder approval, the company intends to change its name to "Healthineers," with the brand migration set to begin in early 2027 and run over three years.
On the capital returns front, Siemens Healthineers reported on Monday the repurchase of 50,000 of its own shares for the period from November 2 through November 8. Since the buyback program began on June 1, the company had repurchased around 3.68 million shares through November 8.
Ad
Siemens Healthineers Stock: New Analysis - 14 November
Fresh Siemens Healthineers information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
